Evaluating the efficacy of psychological therapy;Wirksamkeitsuntersuchungen in der psychotherapieforschung

Verhaltenstherapie

Volumn 12, Issue 3, 2002, Pages 205-215

  Bandelow, Borwin ^a   Broocks, A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Clinical research protocol; Psychotherapy: efficacy; Rating scales; Statistics

Indexed keywords

ARTICLE; EVALUATION; FOLLOW UP; HUMAN; MENTAL DISEASE; PSYCHOTHERAPY; REMISSION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036425963     PISSN: 10166262     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066571     Document Type: Article

References (50)

1. Akritas MG, Brunner E: Rank tests for patterned alternatives in factorial designs with interactions; in Brunner E, Denker M (eds): Research Developments in Probability and Statistics. Festschrift in Honor of Madan L. Puri on the Occasion of the 65th Birthday. Utrecht, VSP International Science Publishers, 1996, pp 277-288.
2. Akritas MG, Brunner E: A unified approach to rank tests in mixed models. J Stat Plann Inference 1997;61:249-277.
3. APA American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders; Ed 4. Washington DC, American Psychiatric Press, 1994.
4. Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP: Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45:413-422.
5. Bandelow B: Panik- und Agoraphobieskala (PAS). Göttingen, Hogrefe, 1997.
6. Bandelow B, Margraf J: Empfehlungen für die verwendung von messinstrumenten in der klinischen angstforschung. Fortschr Neurol Psychiatr 1994;62:361-365.
7. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Archives of General Psychiatry 1961;41:561-571.
8. Bortz J: Statistik für Sozialwissenschaftler; Aufl 5. Berlin, Springer, 1999.
9. Bortz J, Lienert GA: Kurzgefasste Statistik für die klinische Forschung. Berlin, Springer, 1998.
10. Brown WA: Placebo as a treatment for depression. Neuropsychopharmacology 1994;10:265-269; discussion 271-288.
11. Brunner E, Langer F: Nichtparametrische Analyse longitudinaler Daten. München, Oldenbourg, 1999.
12. CIPS: Collegium Internationale Psychiatriae Scalarum - Internationale Skalen für Psychiatrie. Göttingen, Hogrefe, 1996.
13. Cohen J: The statistical power of abnormal-social psychological research. A review. J Abnorm Soc Psychol 1962;65:145-153.
14. Cohen J: Statistical power analysis for the behavioral sciences. New York, Erlbaum, 1988.
15. Crits-Christoph P: The efficacy of brief dynamic psychotherapy: A meta-analysis. Am J Psychiatry 1992;149:151-158.
16. Dilling H, Mombour W, Schmidt MH, Schulte-Markwort E (Hrsg): WHO, Weltgesundheitsorganisation - Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F). Forschungskriterien. Bern, Huber, 1994.
17. Emilien G, Maloteaux JM, Seghers A, Charles G: Use of a placebo in clinical trials. Eur Psychiatry 1998;13:254-263.
18. Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacol Bull 1993;29:321-326.
19. Eysenck H: The effects of psychotherapy - An evaluation. J Consult Psychol 1952;16:319-324.
20. Friedman M: The use of ranks to avoid the assumption of normality implicit in the analysis of variance. J Am Stat Assoc 1937;32:675-699.
21. Grawe K, Donati R, Bernauer F: Psychotherapie im Wandel. Von der Konfession zur Profession. Göttingen, Hogrefe, 1994.
22. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55.
23. Hollon S: Allegiance effects in treatment research: A commentary. Clin Psychol. Sci Pract 1999;6:107-112.
24. Holm S: A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
25. Hsu LM: Regression toward the mean associated with measurement error and the identification of improvement and deterioration in psychotherapy. J Consult Clin Psychol 1995;63:141-144.
26. Jacobson NS, Truax P: Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
27. Lambert MJ, Bergin AE: The effectiveness of psychotherapy; in Bergin AE, Garfield SL (eds): Handbook of Psychotherapy and Behavior Change; Ed 4. New York, Wiley, 1994.
28. Luborsky L, Diguer L, Seligman D, Rosenthal R, Krause E, Johnson S, Halperin G, Bishop M, Berman JS, Schweizer E: The researcher's own therapy allegiances: A 'wild card' in comparisons of treatment efficacy. Clin Psychol Sci Practice 1999;6:95-106.
29. Luborsky L, Singer B, Luborsky L: Comparative studies of psychotherapies. Is it true that 'everyone has won and all must have prizes'? Arch Gen Psychol 1975;32:995-1008.
30. Maier W, Albus M, Buller R, Nutzinger D, Shera D, Bech P: Self- and observer assessment in anxiolytic drug trials - A comparison of their validity. Eur Arch Psychiatry Clin Neurosci 1991;240:103-108.
31. Margraf J, Hoffmann SO: Wissenschaftlicher Beirat Psychotherapie. Anwendungsbereiche von Psychotherapie bei Erwachsenen. Dtsch Ärztebl 2000;97:B52-B56.
32. Michell J: Measurement scales and statistics: A clash of paradigms. Psychol Bull 1986;100:398-407.
33. Montgomery GH, Kirsch I: Classical conditioning and the placebo effect. Pain 1997;72:107-113.
34. Munzel U, Bandelow B: The use of parametric vs. non-parametric tests in the statistical evaluation of rating scales. Pharmacopsychiatry 1998;31:222-224.
35. NIMH. National Institute of Mental Health: 028 CGI. Clinical Global Impressions; in Guy E (ed): ECDEU Assessment Manual for Psychopharmacology. Rockville, Maryland, 1976, pp 217-222.
36. Noyes R Jr., Moroz G, Davidson JR, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Lydiard RB, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, Hedges D, Schweizer E, Uhlenhuth EH: Moclobemide in social phobia: A controlled dose-response trial. J Clin Psychopharmacol 1997;17:247-254.
37. Rosenthal R: Meta-analytic procedures for social research. Beverly Hills, Sage Publications, Applied Social Research Methods Series vol 6, 1984a.
38. Rosenthal R: Meta-analytic procedures for social research. Applied Social Research Methods Series Vol 6. Beverly Hills, Sage, 1984b.
39. Shaw B: How to use the allegiance effect to maximize competence and therapeutic outcomes. Clin Psychol Sci Pract 1999;6:131-132.
40. Sher L: The placebo effect on mood and behavior: The role of the endogenous opioid system. Med-Hypotheses 1997;48:347-349.
41. Smith M, Glass G, Miller I: The Benefits of Psychotherapy. Baltimore, Johns Hopkins University Press, 1980.
42. Smith ML, Glass GV: Meta-analysis of psychotherapy outcome studies. Am Psychol 1977;32:752-760.
43. Stevens SS: On the theory of scales of measurement. Science 1946;103:667-680.
44. Strupp H, Hadley S: Specific vs nonspecific factors in psychotherapy - A controlled study of outcome. Arch Gen Psychiatry 1979;36:1125-1136.
45. Svartberg M, Stiles T: Comparative effects of short-term psychodynamic psychotherapy - A meta-analysis. J Consult Clin Psychol 1991;59:704-714.
46. Tennant C, Bebbington P, Hurry J: The short-term outcome of neurotic disorders in the community: The relation of remission to clinical factors and to 'neutralizing' life events. Br J Psychiatry 1981;139:213-220.
47. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG: The Delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-1241.
48. Wilcox RR: Introduction to Robust Estimation and Hypothesis Testing. San Diego, Academic Press, 1997.
49. Wilcox RR: How many discoveries have been lost by ignoring modern statistical methods? Am Psychologist 1998;3:300-314.
50. Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M: Strukturiertes Klinisches Interview für DSM-IV. Göttingen, Hogrefe, 1997.